通过光化学诱导的癌细胞pH不平衡而导致的选择性细胞死亡
Xiling Yue1, Ciceron O Yanez, Sheng Yao
1Department of Chemistry, University of Central Florida, P.O. Box 162366, Orlando, Florida 32816, USA.
Journal of the American Chemical Society
|January 31, 2013
概括
这项研究引入了一种使用光酸发生器 (PAG) 的新型氧气独立光动力疗法 (PDT). 这些PAG诱导缺氧癌细胞中的细胞死亡,为瘤治疗提供了一个有希望的替代方案.
科学领域:
- 生物医学工程 生物医学工程
- 摄影化学的使用.
- 癌症治疗 癌症治疗
背景情况:
- 光动力学治疗 (PDT) 的有效性受到固体瘤中缺氧的限制.
- 依赖氧气的活性氧物种产生阻碍了低氧环境中的传统PDT.
研究的目的:
- 开发一种独立于氧气的PDT策略.
- 研究光酸生成器 (PAG) 对选择性癌细胞死亡的潜力.
主要方法:
- 合成的硫盐作为PAG.
- 利用一个或两个光子的吸收 (1PA/2PA) 在细胞内产生光酸.
- 在HCT116细胞中评估了PAG诱导的pH值下降和细胞死亡.
主要成果:
- PAG产生光酸,导致HCT 116细胞的pH值下降.
- 一个PAG表现出低暗细胞毒性和高效的光酸生成.
- 在缺氧细胞中观察到有效诱导死细胞死亡.
结论:
- PAG提供了一种可行的无氧PDT方法.
- 这种方法显示出选择性杀死低氧瘤癌细胞的潜力.
- 氧化是一种有吸引力的替代方法来治疗缺氧的组织.
更多相关视频
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
相关概念视频
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
